Company
NYSE · NYSE:LLY
Eli Lilly
Longevity exposure
How this company touches longevity
Tirzepatide + oral orforglipron; XPRIZE Healthspan sponsor.
Recent inflection
What moved lately
Oral orforglipron ("Foundayo") FDA-approved 1 Apr 2026.
Latest moves
Dated developments variis is tracking.
Keep reading
Related coverage from the newsroom.
Every entity profile on variis is sourced. Not investment advice.